You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 23, 2024

Details for New Drug Application (NDA): 087859

✉ Email this page to a colleague

« Back to Dashboard

NDA 087859 describes SPS, which is a drug marketed by Cmp Pharma Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the SPS profile page.

The generic ingredient in SPS is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for 087859
Applicant:Cmp Pharma Inc
Ingredient:sodium polystyrene sulfonate
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 087859
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SPS sodium polystyrene sulfonate SUSPENSION;ORAL, RECTAL 087859 ANDA CMP Pharma, Inc. 46287-006 46287-006-01 473 mL in 1 BOTTLE (46287-006-01)
SPS sodium polystyrene sulfonate SUSPENSION;ORAL, RECTAL 087859 ANDA CMP Pharma, Inc. 46287-006 46287-006-04 120 mL in 1 BOTTLE (46287-006-04)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORAL, RECTALStrength15GM/60ML
Approval Date:Dec 8, 1982TE:AARLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.